We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · September 22, 2022

Risk of Reactivation of Latent Tuberculosis in Patients With Psoriasis Receiving Biologic Therapies

Acta Dermato-Venereologica

 

Additional Info

Acta Dermato-Venereologica
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy
Acta Derm Venereol 2022 Sep 06;[EPub Ahead of Print], L Mastorino, P Dapavo, M Trunfio, G Avallone, M Rubatto, A Calcagno, S Ribero, P Quaglino

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading